Steven L. Hoerter bought $265K of MBX Biosciences (MBX)

Executed Oct 17 2025, disclosed Oct 20 2025, 3 days later.

Value, as filed

$265K

20,000 sh × $13.25

Executed

Oct 17 2025

the trade date, as filed

Disclosed

Oct 20 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+92.3%

+82.5% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 20 2025), the stock returned +92.3% (delay-adjusted); from the execution session (Oct 17 2025), +82.5%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

SH Steven L. Hoerter Director profile →

Steven L. Hoerter (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in MBX. Across 1 priced purchase filing, the average 21-session return was +82.5% from execution and +92.3% from disclosure (delay-adjusted; derived). The largest single filing was $265K of MBX (20,000 sh × $13.25, as filed), executed Oct 17 2025.

The name

MBX MBX MBX · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→